eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Investigational New Drug Applications; Co-Development of Investigational Drugs

Investigational New Drug Applications; Co-Development of Investigational Drugs

Document ID: FDA-2010-N-0247-0001
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2010-13769
View Document:  View as format pdf View as format html

Details Information

Document Subtype: N-Notice
Received Date: June 07 2010, at 12:00 AM Eastern Daylight Time
Start-End Page: 32482 - 32483
Page Count: 2
Comment Start Date: June 8 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: September 7 2010, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 16
Abbott Laboratories - Comment
Posted: 09/16/2010     ID: FDA-2010-N-0247-0003

Sep 07,2010 11:59 PM ET
GlaxoSmithKline - Comment
Posted: 09/16/2010     ID: FDA-2010-N-0247-0004

Sep 07,2010 11:59 PM ET
Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Posted: 09/16/2010     ID: FDA-2010-N-0247-0005

Sep 07,2010 11:59 PM ET
Critical Path Institute - Comment
Posted: 09/16/2010     ID: FDA-2010-N-0247-0006

Sep 07,2010 11:59 PM ET
Gilead Sciences, Inc. - Comment
Posted: 09/16/2010     ID: FDA-2010-N-0247-0007

Sep 07,2010 11:59 PM ET

Related Documents

Total: 0
No documents available.